TEMGESIC Sublingual tablet Ref.[27661] Active ingredients: Buprenorphine

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2020  Publisher: Indivior UK Limited, The Chapleo Building, Henry Boot Way, Priory Park, Hull, HU4 7DY, United Kingdom

Product name and form

Temgesic 200 microgram Sublingual Tablets.

Temgesic 400 microgram Sublingual Tablets.

Pharmaceutical Form

Sublingual tablet.

Temgesic 200 microgram Sublingual Tablets:

White to creamy white, circular, biconvex tablets, embossed on one side with “L”.

Temgesic 400 microgram Sublingual Tablets:

White to creamy white, circular, biconvex tablets, embossed on one side with “H”.

Qualitative and quantitative composition

Temgesic 200 microgram Sublingual Tablets

Buprenorphine hydrochloride 216 µg/tablet, equivalent to 200 µg buprenorphine base.

Excipient(s) with known effect: lactose.

For the full list of excipients, see section 6.1.

Temgesic 400 microgram Sublingual Tablets

Buprenorphine hydrochloride 432 µg/tablet, equivalent to 400 µg buprenorphine base.

Excipient(s) with known effect: lactose.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Buprenorphine

Buprenorphine is an opioid partial agonist/antagonist which attaches itself to the μ (mu) and κ (kappa) receptors of the brain. Its activity in opioid maintenance treatment is attributed to its slowly reversible link with the μ receptors which, over a prolonged period, minimises the need of illicit opioids for patients with opioid dependence.

List of Excipients

Lactose
Mannitol
Maize starch
Povidone k30
Citric acid anhydrous
Magnesium stearate
Sodium citrate
Purified water
Alcohol (96%)

Pack sizes and marketing

Nylon/aluminium/uPVC blister strips of 10 tablets each, packed in cartons of 50 tablets.

HDPE bottle consisting of 50 tablets.

Marketing authorization holder

Indivior UK Limited, The Chapleo Building, Henry Boot Way, Priory Park, Hull, HU4 7DY, United Kingdom

Marketing authorization dates and numbers

Temgesic 200 microgram Sublingual Tablets: PL 36699/0004

Temgesic 400 microgram Sublingual Tablets: PL 36699/0005

11/11/1980 / 17/05/2002

Drugs

Drug Countries
TEMGESIC Austria, Germany, Finland, France, Hong Kong, Ireland, Mexico, Netherlands, New Zealand, Singapore, Tunisia, Turkey, United Kingdom, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.